Subscribe to Newsletter
Business & Regulation Business Practice

Funding Dementia Discovery

| Stephanie Vine

$100 million pledged to kick start investment in new research

Discovery & Development Standards & Regulation

Premature Revelation

| Stephanie Vine

FDA scolds company for revealing interim trial results

Business & Regulation Packaging

Personalized Labels

| Stephanie Vine

Just how prevalent is pharmacogenomic information on European drug labels?

Business & Regulation Business Practice

Mining Social Media

| Stephanie Vine

New technology interprets slang and banter to find out what people really think

Manufacture Small Molecules

Rewarding Humanity

| Stephanie Vine

An antimalarial medicine-making project wins the inaugural Humanity in Science Award.

Discovery & Development Clinical Trials

Silent Data

| Stephanie Vine

Information from “stalled” drug trials should be published, not tossed aside

Manufacture Biosimilars

America’s Most Wanted: Biosimilars

| Charlotte Barker

We catch up with Carol Lynch, Global Head of Biopharmaceuticals & Oncology Injectables at Sandoz.

Manufacture Small Molecules

Practical Innovation

| Charlotte Barker

It's important to remember that innovation in pharma isn’t synonymous with drug discovery.

Manufacture Business Practice

A Fresh Pair of Eyes

| Stephanie Vine

Global healthcare company GlaxoSmithKline (GSK) has pledged to be carbon neutral by 2050.

Discovery & Development Ingredients

Sustainable Ingredients

| Daniele Piergentili

Climate change, health challenges, and resource inefficiencies or shortages are very high on the agenda of societies around the world. And rightly so

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register